Thus RAF1 ablation and, to a lesser extent, downregulation, impacts the proliferation of spheroids derived from 5 CRC cell lines that differ with respect to their KRAS mutation status, MSI/MSS phenotype, and CMS classification (Supplementary Table 2). This evidence concerns the gene KRAS and colorectal carcinoma.